Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark N Levine

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
European Journal of Haematology|April 11, 2022
Important questions for the malignant hematologist to consider when designing or evaluating a study with patient-reported outcome measures (PROMs)Amaris K Balitsky, Anita D'Souza, Mark N Levine
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
neu/erbB-2 overexpression and response to hormonal therapy in premenopausal women in the adjuvant breast cancer setting: will it play in Peoria? part IIKathleen I Pritchard, Mark N Levine, Dongsheng Tu
The New England Journal of Medicine|November 1, 2023
Omitting Radiotherapy in Luminal A Breast Cancer. ReplyTimothy J Whelan, Sameer Parpia, Mark N Levine
The New England Journal of Medicine|November 5, 2015
Regional Nodal Irradiation in Early-Stage Breast CancerTimothy J Whelan, Ivo A Olivotto, Mark N Levine
Chest|July 24, 2008
Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Sam Schulman, Rebecca J Beyth, Clive Kearon, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2003
Thrombotic disorders: diagnosis and treatmentAndrew I Schafer, Mark N Levine, Barbara A Konkle, et al.
JCO Clinical Cancer Informatics|August 2, 2019
Learning Health System for Breast Cancer: Pilot Project ExperienceMark N Levine, Gordon Alexander, Arani Sathiyapalan, et al.
Chest|September 24, 2004
Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyMark N Levine, Gary Raskob, Rebecca J Beyth, et al.
Springerplus|July 15, 2014
Interim analysis for binary outcome trials with a long fixed follow-up time and repeated outcome assessments at pre-specified timesSameer Parpia, Jim A Julian, Chushu Gu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 2024
LUMINA: Using molecular biomarkers to guide decision making for breast radiotherapyTimothy J Whelan, Anthony Fyles, Sameer Parpia, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
European Journal of Haematology|April 11, 2022
Important questions for the malignant hematologist to consider when designing or evaluating a study with patient-reported outcome measures (PROMs)Amaris K Balitsky, Anita D'Souza, Mark N Levine
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
neu/erbB-2 overexpression and response to hormonal therapy in premenopausal women in the adjuvant breast cancer setting: will it play in Peoria? part IIKathleen I Pritchard, Mark N Levine, Dongsheng Tu
The New England Journal of Medicine|November 1, 2023
Omitting Radiotherapy in Luminal A Breast Cancer. ReplyTimothy J Whelan, Sameer Parpia, Mark N Levine
The New England Journal of Medicine|November 5, 2015
Regional Nodal Irradiation in Early-Stage Breast CancerTimothy J Whelan, Ivo A Olivotto, Mark N Levine
Chest|July 24, 2008
Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Sam Schulman, Rebecca J Beyth, Clive Kearon, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2003
Thrombotic disorders: diagnosis and treatmentAndrew I Schafer, Mark N Levine, Barbara A Konkle, et al.
JCO Clinical Cancer Informatics|August 2, 2019
Learning Health System for Breast Cancer: Pilot Project ExperienceMark N Levine, Gordon Alexander, Arani Sathiyapalan, et al.
Chest|September 24, 2004
Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyMark N Levine, Gary Raskob, Rebecca J Beyth, et al.
Springerplus|July 15, 2014
Interim analysis for binary outcome trials with a long fixed follow-up time and repeated outcome assessments at pre-specified timesSameer Parpia, Jim A Julian, Chushu Gu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 2024
LUMINA: Using molecular biomarkers to guide decision making for breast radiotherapyTimothy J Whelan, Anthony Fyles, Sameer Parpia, et al.
Pageof 12